Medical News

RSS

Clinical markers help identify PD patients with cholinergic deficits

Assessing patients for clinical markers of cholinergic system denervation is viable and can help identify suitable individuals for trials of new anticholinergic drugs, researchers believe.

9 Dec 2014

PAH markers identified among Chinese systemic sclerosis patients

A study of Chinese patients with systemic sclerosis has identified predictive markers for accompanying pulmonary arterial hypertension similar to those that have been identified in other ethnic groups.

9 Dec 2014

PD-1, PD-L1 differentially expressed in NSCLC

The expression of the immune checkpoint protein programmed death-1 receptor and its ligand varies according to tumour and patient characteristics in oncogene-addicted non-small-cell lung cancer, research indicates.

9 Dec 2014

Quitting cannabis use during manic episodes improves outcomes

A post-hoc analysis of data from a prospective European study reveals that patients with bipolar disorder who stop using cannabis during a manic or mixed episode have similar clinical and functional outcomes to those who have never used the drug.

9 Dec 2014

Cardiac monitoring foretells clinical deterioration in PAH

Monitoring right ventricular parameters can give advance warning of clinical deterioration in stable patients with idiopathic pulmonary arterial hypertension, research suggests.

9 Dec 2014

Ponatinib ‘superior’ to sequential second-generation TKI treatment in CML

Patients with chronic myelogenous leukaemia resistant or intolerant to at least one second-generation tyrosine kinase inhibitor have a higher probability of achieving a response to the third-generation TKI ponatinib than to a further second-generation TKI, research indicates.

9 Dec 2014

At-home test sniffs out prodromal Parkinson’s disease

An at-home olfactory test helps to identify people with an increased risk of having dopamine transporter imaging indicative of early Parkinson’s disease, show data from the Parkinson Associated Risk Syndrome study.

9 Dec 2014

Excess mortality in schizophrenia ‘not attributable to antipsychotics’

The relationship between antipsychotic use and mortality in people with schizophrenia shows a clear U-shape curve, with the highest risk of death seen in those with no antipsychotic exposure, a Swedish cohort study has found.

9 Dec 2014

Simple blood test could help to detect breast cancer early

It may be possible to develop a simple blood test that, by detecting changes in the zinc in our bodies, could help to diagnose breast cancer early.

9 Dec 2014

MOVENTIG (naloxegol) receives EC approval for treatment of opioid-induced constipation

Nektar Therapeutics reported partner AstraZeneca today announced that MOVENTIG (naloxegol) has been granted Marketing Authorisation by the European Commission for the treatment of opioid-induced constipation (OIC) in adult patients who have had an inadequate response to laxative(s).

9 Dec 2014

Rey Colon launches telemedicine platform to help healthcare providers meet rising medical needs

Aging Baby Boomers, increasing healthcare demands, introduction of compulsory medical insurance rules of the Affordable Care Act and shortage of doctors paint a grim situation for healthcare in America. The healthcare industry is struggling to cope with these challenges. Keeping this scenario in consideration, Rey Colon, former partner and Chief Marketing Officer of AmeriDoc, a national telemedicine service provider, recently launched MyTelemedicine.com to help healthcare providers meet rising medical needs.

9 Dec 2014

Latest version of iMedX Mobile app released for physicians

iMedX, a leading health information solutions company and a leader in medical documentation solutions, today announced that it released the next version of iMedX Mobile: an iOS app that enables highly secure, HIPAA-compliant medical documentation capture and access for physicians via iPhone or iPad anytime, anywhere. The solution is available in the Apple App store for free to physicians and other clinicians using iMedX documentation solutions.

9 Dec 2014

Focus Diagnostics' Simplexa Flu A/B & RSV Direct Kit receive FDA clearance

As the 2014-2015 flu season begins, Focus Diagnostics, the products business of Quest Diagnostics, today announced that its Simplexa Flu A/B & RSV Direct Kit has received FDA clearance for eight additional influenza strains. These strains may pose significant potential health risks and may be circulating this winter.

From Quest Diagnostics 9 Dec 2014

Banner Health chooses Craneware's Chargemaster Corporate Toolkit to support ongoing growth

With healthcare consolidation on the rise, Craneware, Inc., the healthcare market leader in automated revenue integrity solutions, today announced that Banner Health, one of the largest not-for-profit healthcare systems in the US, has selected Craneware's Chargemaster Corporate Toolkit to support its ongoing growth and efficient integration across newly acquired facilities.

9 Dec 2014

$Vaccinex completes VX15/2503 Phase 1 clinical trial in patients with advanced, refractory solid tumors$

Vaccinex completes VX15/2503 Phase 1 clinical trial in patients with advanced, refractory solid tumors

Vaccinex, Inc. today announced the successful completion of a multicenter Phase 1, multiple ascending dose clinical trial of VX15/2503 anti-Semaphorin 4D (SEMA4D) antibody in 42 adult patients with advanced, refractory solid tumors.

9 Dec 2014

Cannabis Science, CFA partner to improve health-related education infrastructure in Africa

Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is pleased to announce its President & CEO, Mr. Raymond C. Dabney, along with CBIS's Senior Scientific Advisor, Dr. Roscoe M. Moore, Jr., have initiated a partnership between CBIS and the Constituency for Africa to help improve the healthcare and health-related education infrastructure in Africa.

9 Dec 2014

Can-Fite to commence pre-clinical development program of CF602 drug for sexual dysfunction

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today reported that it will initiate a pre-clinical development program of its next generation drug CF602 for the indication of sexual dysfunction. Upon successful completion, the company intends to file an IND with the FDA to allow human Phase I studies.

9 Dec 2014

ContraVir begins pharmacokinetic study of FV-100 for treating shingles

ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it has initiated a pharmacokinetic (PK) study of FV-100, the Company's clinical-stage antiviral for treating shingles.

9 Dec 2014

Arthritis drug baricitinib meets primary endpoint in Phase 3 RA-BEACON study

Eli Lilly and Company and Incyte Corporation today announce that the Phase 3 RA-BEACON study of the investigational medicine baricitinib met its primary endpoint of improved ACR20 response compared to placebo after 12 weeks of treatment.

9 Dec 2014

Novartis' JUMP study reinforces safety, efficacy of Jakavi (ruxolitinib) for myelofibrosis treatment

Novartis today announced data from the largest clinical trial of myelofibrosis patients treated with Jakavi (ruxolitinib), supporting the safety profile and efficacy benefit as measured in primary and secondary endpoints respectively.

9 Dec 2014

Medical News

Clinical markers help identify PD patients with cholinergic deficits

PAH markers identified among Chinese systemic sclerosis patients

PD-1, PD-L1 differentially expressed in NSCLC

Quitting cannabis use during manic episodes improves outcomes

Cardiac monitoring foretells clinical deterioration in PAH

Ponatinib ‘superior’ to sequential second-generation TKI treatment in CML

At-home test sniffs out prodromal Parkinson’s disease

Excess mortality in schizophrenia ‘not attributable to antipsychotics’

Simple blood test could help to detect breast cancer early

MOVENTIG (naloxegol) receives EC approval for treatment of opioid-induced constipation

Rey Colon launches telemedicine platform to help healthcare providers meet rising medical needs

Latest version of iMedX Mobile app released for physicians

Focus Diagnostics' Simplexa Flu A/B & RSV Direct Kit receive FDA clearance

Banner Health chooses Craneware's Chargemaster Corporate Toolkit to support ongoing growth

Vaccinex completes VX15/2503 Phase 1 clinical trial in patients with advanced, refractory solid tumors

Cannabis Science, CFA partner to improve health-related education infrastructure in Africa

Can-Fite to commence pre-clinical development program of CF602 drug for sexual dysfunction

ContraVir begins pharmacokinetic study of FV-100 for treating shingles

Arthritis drug baricitinib meets primary endpoint in Phase 3 RA-BEACON study

Novartis' JUMP study reinforces safety, efficacy of Jakavi (ruxolitinib) for myelofibrosis treatment

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News